# Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

> **NCT00894465** · NA · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 44 (actual)

## Conditions studied

- Vesicoureteral Reflux

## Interventions

- **DRUG:** midazolam
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00894465
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2009-06
- **Final completion:** 2009-08
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** Most pts requested to be treated with versed. It was difficult to randomize pts.
- **Last updated:** 2016-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894465, "Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT00894465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
